Hormone therapy and breast cancer risk: new screening study launches
NCT ID NCT06383026
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is for people aged 40-75 who are on hormone therapy (estrogen, progesterone, or testosterone). It aims to understand their breast cancer risk and improve screening by using mammograms and breast ultrasounds. Researchers will also interview participants to learn about their experiences and any barriers to getting screened.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help design better breast cancer screening programs tailored for people on hormone therapy.
- What could go wrong
- This is a small pilot study (130 participants) focused on gathering data, not testing a treatment. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?